Semaglutide and other GLP-1 receptor agonists have transformed weight loss treatment, but reports of hair loss concern many patients considering therapy
Disclaimer: This article is for educational purposes only and does not replace personalised medical advice, diagnosis, or treatment
Consent for Publication All authors read and approved the final manuscript
Tirzepatide: Mechanism: It's a dual agonist that mimics both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Testing & COA: Publishes batch-specific Certificates of Analysis for purity, sterility, and endotoxins, so open the report that matches your lot before you buy
Together, they create a hormonal environment that strongly favors fat oxidation over fat storage